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lias Zerhouni, former NIH Director, charged the NIH with building a biomedi-
cal research enterprise that enhanced the translation of scientific discoveries 
into improved health care for our nation (1). One component of that charge 
was to establish the NIH Clinical and Translational Science Award (CTSA) program, 
which currently is located in the National Center for Advancing Translational Scienc-
es (http://www.ncats.nih.gov/research/cts/ctsa/ctsa.html. The goals of the CTSA pro-
gram are 1) to improve the manner by which medical research is performed in the 
US, 2) to move discoveries in the lab more quickly into the clinic, 3) to integrate clini-
cal research into communities, and 4) to train the next generation of medical re-
searchers in the art of clinical and translational research. Approximately 60 institu-
tions in 30 states including the District of Columbia and Kansas are part of the CTSA 
consortium working toward these goals. 
 
Headquartered at the University of 
Kansas Medical Center, the NIH-CTSA-
supported Frontiers program, more 
formally called The Heartland Institute 
for Clinical and Translational Research, 
is a network of scientists from institu-
tions in Kansas and the Kansas City re-
gion (www.FrontiersResearch.org). The 
Frontiers program is developing more 
efficient use and integration of bio-
repositories, genomic information and 
biomedical informatics which are im-
portant components for attaining the 
CTSA goals. Specific goals of Frontiers 
are to: 1) create a new academic home 
with innovative education and training 
programs for clinical and translational 
investigators that will transform the 
type, and increase the number of faculty 
and investigators needed to bring dis-
coveries and research findings more rap-
idly to the point of care; 2) provide an 
enhanced coordinated translational re-
search infrastructure that will speed the 
process from discovery to community 
research in Kansas and the Kansas City 
region; and 3) actively engage the com-
munity in developing, testing, and dis-
seminating translational research 
through existing and new networks in 
Kansas and the Kansas City region. 
 
1 Vice Chancellor for Research; 2 Director, Frontiers; 3 Deputy Director, Frontiers; 4 Professor & Director, 
Molecular Oncology; 5 Director, Institute for Neurological Discoveries, Co-Director, KIDDRC; 6 Direc-
tor, Medical Informatics. 
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The infrastructure needed (Frontiers 
goal #2) to speed the process of discov-
ery, includes, in part, fundamental com-
ponents such as bio-repository, ge-
nomics, and biomedical informatics. 
Each of these promotes and enhances 
discovery and each is foundational for 
moving discoveries from the bench to the 
bedside and becomes the foundation for 
this presentation. Each of these is de-
scribed in order to provide an overview 
of how each is a component of transla-
tional research. 
Frontiers: The Heartland Institute for 
Clinical and Translational Research 
Many partners are involved with ac-
complishing the goals of our Frontiers 
program. These partners include aca-
demic institutions (University of Kansas 
Medical Center in Kansas City, Universi-
ty of Kansas School of Medicine in Wich-
ita, University of Kansas at Lawrence, 
University of Missouri at Kansas City, 
and the Kansas City University of Medi-
cine and Biosciences) and health care in-
stitutions and centers in the region (Uni-
versity of Kansas Hospital, Wesley Med-
ical Center in Wichita, Via Christi Health 
System in Wichita, Kansas City, VA 
Medical Center, Children’s Mercy Hospi-
tals and Clinics, St. Luke’s Health Sys-
tem, Truman Medical Center, Swope 
Health Services, Center for Behavioral 
Medicine, and Center for Practical Bio-
ethics. The basic infrastructure of Fron-
tiers includes several components de-
scribed below.  
1. Clinical Research Development Of-
fice. This is the literal and virtual (via 
a web portal) front door where inves-
tigators go to access information 
about services and resources. Infor-
mation on the investigators research 
interests are logged so they may be 
contacted by Frontiers faculty regard-
ing special initiatives and for collabo-
ration. Thus, this office brings to-
gether the scientific expertise and 
other resources to support faculty 
projects, ensuring appropriate multi-
disciplinary contribution and inclu-
sion of relevant components of the 
CTSA such as biostatistics, biomedi-
cal informatics, community engage-
ment and ethics programs.  
2. Clinical and Translational Research 
Education Center. This is the site of 
educational and career development 
programs that use teaching and 
learning technologies and facul-
ty/staff to educate students and facul-
ty at many levels of development. 
This Center provides innovative pro-
grams for mentoring skills and de-
velopment, formal training in the en-
trepreneurial skills necessary to bring 
new discoveries to the market, and a 
program for minority recruitment 
and retention. This Center also in-
cludes a NIH TL1 pre-doctoral pro-
gram and a NIH KL2 post-doctoral 
program. In addition to formal train-
ing in research methods, scholars and 
trainees take advantage of a mentor-
ship program and become integrated 
into multidisciplinary research 
teams. 
3. Biomedical Informatics. This pro-
gram provides information re-
sources, services, and communication 
technologies in support of transla-
tional research. Russ Waitman, PhD, 
associate professor and director of 
Medical Informatics in the Depart-
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ment of Biostatistics leads this pro-
gram and is providing a chapter on 
this topic in this Merrill conference 
(2012). The program has several 
goals: a) to provide a portal for inves-
tigators to access clinical and transla-
tional research resources, track usage 
and outcomes, and provide informat-
ics consultation services; b) to create 
a repository to integrate clinical and 
biomedical data for translational re-
search aligned with national stand-
ards; c) to advance medical innova-
tion by linking biological tissues to 
clinical phenotype and research la-
boratory results for phase I and II 
clinical trials; and d) to leverage an 
active, engaged statewide telemedi-
cine and Health Information Ex-
change to enable community based 
translational research. 
4. Biostatistics. This program, offered 
through the Department of Biostatis-
tics, provides the statistical and data 
management support for Frontiers 
studies. 
5. Clinical and Translational Science 
Unit (CTSU). This unit is a new state-
of-the-art facility with capability to 
conduct first-in-human proof of con-
cept trials as well as traditional clini-
cal research activities within the unit 
and in clinics and the community 
(using our “CTSU without Walls”). 
This program also developed a clini-
cal research participant identification 
and registration system that our Bi-
omedical Informatics program is fur-
ther developing to provide easy co-
hort identification and contact infor-
mation on patients willing to consid-
er participating in research and to in-
corporate national developments in 
this area. 
6. The Institute for Advancing Medical 
Innovations. This program provides 
infrastructure for drug and device 
development that lead to clinical ap-
plications. 
7. Translational Technologies Resource 
Center. This program provides access 
to specific technologies through four 
cores: In vivo Imaging, Cell and Tis-
sue Imaging, Molecular Biomarkers, 
and a Biological Tissue Repository. 
The overall goal of this program is to 
eliminate barriers to incorporating 
new technologies and research ap-
proaches into research studies for 
both new and seasoned investigators 
by providing access to equipment 
and expert faculty collaborators in 
these technologies. 
8. Pharmacokinet-
ics/Pharmacodynamics (PK/PD). This 
program provides PK/PD support to 
investigators who prefer to focus on 
other aspects of their investigator-
initiated trials. The program also 
supports clinical and translational re-
search by training investigators who 
wish to develop such skills to become 
competent in designing, analyzing 
and interpreting PK/PD data ob-
tained from their investigator-
initiated trials, and by providing a 
training ground for graduate and 
post-doctoral students on PK/PD. 
9. Personalized Medicine and Out-
comes Center. This program focuses 
on T2 research innovations and sup-
port and has five cores: Analysis of 
Large Databases; Quality Assess-
ment/Quality Improvement Analysis; 
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Economics, Health Status & Decision 
Analysis; Survey Design and Qualita-
tive Research Support; and Outcomes 
Education. 
10. Pilot and Collaborative Studies Fund-
ing. This program serves as the cen-
tralized Frontiers resource and cata-
lyst for soliciting, reviewing, award-
ing and tracking clinical and transla-
tional research pilot and feasibility 
studies. 
11. Community Partnership for Health. 
This program supports and assists 
investigators with accessing diverse 
populations for participation in clini-
cal and community based research 
projects—historically one of the larg-
er barriers for many clinical investi-
gators. It ensures investigators are 
skilled and knowledgeable about 
working in and with diverse com-
munities through a novel training 
and certification program on com-
munity engagement for research. 
This program is provided online and 
will be coordinated with all other an-
nual investigator certifications (e.g., 
on Human Subjects and Biosafety) 
required for maintaining Institutional 
Review Board approvals. 
12. Regulatory Knowledge and Support. 
This program supports investigators 
to ensure their clinical and transla-
tional research is in compliance with 
ethical and regulatory standards. 
13. Ethics. This program provides indi-
vidual ethics consultations to Fron-
tiers investigators and formal re-
search ethics education and training 
programs.  
Bio-repository 
The bio-repository includes numer-
ous components requiring integration of 
multiple sources of information flow 
with a goal of enhancing discovery to 
improve health. The bio-sample reposi-
tory has several major functions includ-
ing recruitment, sample acquisition, pro-
cessing, storage, distribution and analy-
sis. The repository also includes tissues, 
bodily fluids and cell lines. The process 
usually begins with recruitment and in-
formed consent of the patient in order to 
collect bodily tissue and/or fluids (e.g., 
serum or plasma). Informed consent may 
occur during pre-admission testing, an 
outpatient visit or upon admission to the 
hospital. Sample collection may occur in 
the hospital, operating room and/or out-
patient clinic. Samples are proactively 
acquired for future testing and may 
eventually be sent to multiple recipients. 
Information on personal and family his-
tories, clinical intervention, and lifestyle 
factors is collected for each sample as 
well as: demographic, family history, 
medical history, epidemiologic risk fac-
tors, and clinical history. Annotated, 
high quality samples are collected and 
stored. Specific procedures are followed 
for the tissue banking scheme. For ex-
ample, surgical specimens are collected 
by the pathologist with the aid of their 
physician assistant. Select tissue is identi-
fied for sampling and this information is 
entered into a database. A sample is then 
snap frozen and kept in liquid nitrogen 
or prepared for frozen sectioning. Sam-
ples frozen in liquid nitrogen may be 
stored and/or prepared for DNA and 
RNA extraction. Another sample of the 
same tissue is placed in fixative for sub-
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sequent histopathological analysis by 
storing in paraffin blocks for subsequent 
preparation of histological sections in-
cluding routing staining, immuno-
staining, or tissue microarrays. Blood is 
separated into serum or plasma, red 
blood cells, leukocytes, DNA and stored 
at -80C. Blood samples are banked with-
in 4 hours of draw after being barcoded. 
Sample quality is critical to the success of 
the bio-repository. Quality measures tak-
en include compliance with best practic-
es, qualification for membership in the 
International Society for Biological and 
Environmental Repositories, insisting on 
standard operating procedures, and cer-
tification by the College of American 
Pathologists (and others). NIH support-
ed projects and others will/may require 
appropriate mechanisms for data shar-
ing. Thus, patient consent, sample pro-
cessing and inventory, questionnaire da-
ta, medical records and tumor registry 
data (when appropriate) must all be 
stored in databases, managed, and ap-
propriate samples identified when re-
quests are made for procurement. Bio-
repository management is complex with 
many components requiring oversight 
such as equipment, supplies, dedicated 
resources, liability, data management, 
standard policies and procedures, quali-
ty control, and compliance. Access to 
bio-samples is regulated by an advisory 
committee which considers requests 
from within and outside of the medical 
center. 
Our goal is to enter genome and 
other types of ‘omic’ data such as metab-
olome, transcriptome and proteome into 
the system. Thus, sequencing data, geno-
type, methylation, expression, single nu-
cleotide polymorphism data, chromatin 
remodeling, etc. are collected and en-
tered. The samples are annotated and the 
data placed in the Healthcare Enterprise 
Repository for Ontological Narration 
(HERON—see Waitman presentation in 
this Merrill series, 2012). HERON also 
integrates with billing records, medical 
records, and the KU Hospital Tumor 
Registry along with all of the ‘omic’ and 
other types of data. The Bio-sample Re-
pository supports several programs in-
cluding, Frontiers, Early Detection Re-
search Network, Alzheimer’s Disease 
Center, Clinical Trials and Protocol Sup-
port Lab, the Consortium of Investiga-
tors of Modifiers of BRCA1/2, Pharma-
ceutical and Biotech collaborations, the 
Triple Negative Breast Cancer Network, 
faculty collaborations including investi-
gator initiated studies, and the Gyneco-
logical Oncology working group.  
Compliance is important in the bio-
repository and includes federal and local 
components such as Health Insurance 
Portability and Accountability Act and 
Institutional Review Board of protocols.  
Bioinformatics Services 
Bioinformatics services (http://www2. 
kumc.edu/siddrc/bioinformatics) at KUMC 
are provided largely by the Smith  
Intellectual and Developmental  
Disabilities Research Center (SIDDRC; 
http://www2.kumc.edu/siddrc/) which is 
a collaborative effort with KU at Law-
rence (http://kiddrc.kumc.edu/). The 
Center is supported by a NIH grant 
(HD002528), which has been held for 47 
consecutive years and the grant will con-
tinue at least into its 50th year. Additional 
support for bioinformatics comes from 
NIH including the Center for Biomedical 
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Research Excellence in Cell and Devel-
opmental Biology (RR024214) and the 
Kansas Idea Network of Biomedical Re-
search Excellence (GM103418, 
RR016475). Bioinformatics studies and 
utilizes methods for storing, retrieving 
and analyzing biological data, such as 
DNA, RNA, proteins and their sequence 
as well as their structure, function, 
pathways and interactions. The overall 
mission of the core facility is to advance 
the understanding of integrative func-
tions in biological systems, including 
human, through the application of com-
putational models and data analysis with 
focus on Next Generation Sequencing 
Data Analysis and Microarray Data 
Analysis. The Bioinformatics core pro-
vides consulting, data analysis solutions 
and analysis of large-scale biological da-
tasets produced by high-throughput ge-
nomics experiments. Thus, the core iden-
tifies opportunities and implements solu-
tions for managing, visualizing, analyz-
ing, and interpreting genomic data, in-
cluding studies of gene expression 
(RNA-seq and microarrays), pathway 
analysis, protein-DNA binding (e.g. 
ChIP-seq), DNA methylation, and DNA 
variation, using high-throughput plat-
forms in both human and model organ-
isms. 
A variety of services in bioinformat-
ics and computational biology are pro-
vided by the Bioinformatics Core. For 
example: 
High-throughput sequencing  
• RNA-Seq: provides an unbiased 
deep coverage and base level resolu-
tion of the whole transcriptome.  
• Chip-Seq: combines chromatin im-
munoprecipitation with high-
throughput sequencing to provide an 
unbiased whole genome mapping of 
the binding sites of DNA-associated 
proteins. 
• Whole Genome Sequencing: se-
quences the whole DNA sequence of 
an organism’s genome.  
• De novo Sequencing: provides the 
primary genetic sequence of an or-
ganism. 
• Metagenomic Sequencing: sequenc-
ing and identifying the genomes of 
whole microbial communities. 
• Methyl-Seq: analysis of methylation 
patterns on a genome wide scale.  
Microarray analysis 
• Affymetrix 3’ Expression Arrays: 
target the 3’ end of genes.  
• Affymetrix Exon Arrays: provides 
expression levels for every known 
exon in the genome. 
• Affymetrix miRMA Arrays: pro-
vides measurements of small non-
coding RNA transcripts involved in 
gene regulation. 
• Affymetrix Genome-Wide Human 
SNP Array: copy number analysis 
• Affymetrix GeneChip Tiling Arrays: 
gene regulation analysis  
Biological Functional and Pathway 
Analysis: software from Ingenuity Sys-
tems analyzes expression data to ascer-
tain the top biological functions and 
pathways associated with them.  
Biological Literature Survey: software 
from Acumenta (Literature Lab) that per-
forms data mining tasks on experimen-
tally derived gene lists. 
miRNA Target Prediction: in house 
software and open source software such 
as TargetScan, miRanda for detecting 
genomic targets for miRNAs. 
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Transcription Factor Binding Site Pre-
diction: in house software and open 
source software such as MEME, Homer, 
PGMotifScan to identify protein DNA 
interaction sites. 
Medical Informatics 
The KUMC Medical informatics 
program is discussed in more detail in 
another chapter of this Merrill document 
(2012). The work of the medical infor-
matics division (within the Department 
of Biostatistics in the School of Medicine) 
includes the following: 
• HERON 
(http://informatics.kumc.edu/work/w
iki/HERON) healthcare enterprise 
repository  
• CRIS 
(http://biostatistics.kumc.edu/bio_cris
.shtml) Comprehensive Research In-
formation System powered by Velos 
• REDCap 
(http://informatics.kumc.edu/work/search
?q=redcap) for REDCap at KUMC and 
(http://project-redcap.org/) for RED-
Cap at the CTSA consortium. 
• RequestTracking 
(http://informatics.kumc.edu/work/w
iki/RequestTracking) place for notes 
on using REDCap for request track-
ing (CTSA, ADC, HERON)  
• EnterpriseAnalytics 
(http://www2.kumc.edu/aa/ir/)  
• TEAL data warehouse 
(http://informatics.kumc.edu/wor
k/wiki/TEAL)  
• NetworkInnovation 
(http://informatics.kumc.edu/work/w
iki/NetworkInnovation)  
• Other informatics efforts at the Uni-
versity of Kansas not mentioned in 
the article above include:  
• The Center for Health Informatics 
(http://www2.kumc.edu/healthinf
ormatics/)  
• The Center for Bioinformatics 
(http://www.bioinformatics.ku.ed
u)  
• The K-INBRE Bioinformatics 
Core 
(http://www.kumc.edu/kinbre/bi
oinformatics.html)  
• Bioinformatics Computational 
Biology Laboratory 
(http://www.ittc.ku.edu/bioinfor
matics/)  
• Biodiversity Informatics 
(https://journals.ku.edu/index.ph
p/jbi)  
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